Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | METAP2 | P50579 | 3/20 | 1.00 |
| ▸ | METAP1 | P53582 | 3/20 | 1.00 |
| ▸ | GLRA3 | O75311 | 2/20 | 0.58 |
| ▸ | GLRB | P48167 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 4/20 | 0.52 |
| ▸ | SLC40A1 | Q9NP59 | 3/20 | 0.52 |
| ▸ | G6PD | P11413 | 1/20 | 0.52 |
| ▸ | NFKBIA | P25963 | 1/20 | 0.52 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.52 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.52 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.52 |
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 2/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30309411 | 1.00 | METAP2 (1.00) | METAP2METAP1GLRA3GLRBLMNA | |
| SCHEMBL28581571 | 0.88 | METAP2 (0.78) | METAP2METAP1GLRA3GLRBLMNA | |
| SCHEMBL27974930 | 0.87 | METAP2 (0.76) | METAP2METAP1GLRA3GLRBLMNA | |
| SCHEMBL3263766 | 0.87 | METAP2 (0.76) | METAP2METAP1GLRA3GLRBLMNA | |
| SCHEMBL18419283 | 0.82 | METAP2 (0.69) | METAP2METAP1LMNASLC40A1AGTR1 | |
| SCHEMBL7257985 | 0.82 | METAP2 (0.69) | METAP2METAP1GLRA3GLRBLMNA | |
| SCHEMBL21306590 | 0.79 | METAP2 (0.65) | METAP2METAP1LMNASLC40A1AGTR1 | |
| SCHEMBL19568045 | 0.79 | METAP2 (0.65) | METAP2METAP1GLRA3GLRBLMNA | |
| SCHEMBL10815877 | 0.79 | METAP2 (0.65) | METAP2METAP1GLRA3GLRBLMNA | |
| SCHEMBL1831164 | 0.79 | METAP2 (0.65) | METAP2METAP1GLRA3GLRBLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 261 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250354931-A1 | SPATIAL TARGETING OF ANALYTES | 10X GENOMICS INC (US) | 2025-11-20 | — | — | US | claimed |
| US-12399123-B1 | Spatial targeting of analytes | 10X GENOMICS, INC. (US) | 2025-08-26 | — | — | US | claimed |
| US-20240197884-A1 | COMPOSITIONS AND METHODS FOR TARGETED TUMOR IMMUNOTHERAPY | DANA FARBER CANCER INST INC (US) | 2024-06-20 | — | — | US | claimed |
| US-20200306376-A1 | COMPOSITIONS AND METHODS FOR TARGETED TUMOR IMMUNOTHERAPY | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2020-10-01 | — | — | US | claimed |
| CN-110545847-A | Compositions and methods for targeted immunotherapy of tumors | DANA FARBER CANCER INST INC | 2019-12-06 | — | — | CN | claimed |
| WO-2018200713-A1 | COMPOSITIONS AND METHODS FOR TARGETED TUMOR IMMUNOTHERAPY | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2018-11-01 | — | — | WO | claimed |
| US-20160297820-A1 | DIMERIZER COMPOUND | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2016-10-13 | — | — | US | claimed |
| WO-2015034440-A2 | A Dimerizer Compound | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2015-03-12 | — | — | WO | claimed |
| EP-2649102-A1 | POLYMERS FUNCTIONALIZED WITH OXIME COMPOUNDS CONTAINING AN ACYL GROUP | Bridgestone Corporation (JP) | 2013-10-16 | — | — | EP | claimed |
| WO-2012078962-A1 | POLYMERS FUNCTIONALIZED WITH OXIME COMPOUNDS CONTAINING AN ACYL GROUP | BRIDGESTONE CORPORATION (JP) | 2012-06-14 | — | — | WO | claimed |
| US-20120077941-A1 | POLYMERS FUNCTIONALIZED WITH PROTECTED OXIME COMPOUNDS | BRIDGESTONE CORPORATION (JP) | 2012-03-29 | — | — | US | claimed |
| US-8088868-B2 | oximation of cojugated homopolymers formed by addtion polymerization of conjugated diene monomer in the presence lanthanide copmpounds as polymerization catalysts; polymers used in the manufacture of tires having reduced hysteresis | BRIDGESTONE CORPORATION (JP) | 2012-01-03 | — | — | US | claimed |
| US-20080146745-A1 | POLYMERS FUNCTIONALIZED WITH PROTECTED OXIME COMPOUNDS | BRIDGESTONE CORPORATION (JP) | 2008-06-19 | — | — | US | claimed |
| US-12630859-B2 | Method for transcriptome analysis of single cells | HIFIBIO SAS (FR) | 2026-05-19 | — | — | US | disclosed |
| US-20260132451-A1 | RESOLVING SPATIAL ARRAYS BY PROXIMITY-BASED DECONVOLUTION | 10X GENOMICS, INC. (US) | 2026-05-14 | — | — | US | disclosed |
| US-12618832-B2 | Identification of cognate pairs of ligands and receptors | PARIS SCIENCES ET LETTRES (FR) | 2026-05-05 | — | — | US | disclosed |
| WO-2012078962-A1 | POLYMERS FUNCTIONALIZED WITH OXIME COMPOUNDS CONTAINING AN ACYL GROUP | BRIDGESTONE CORPORATION (JP) | 2012-06-14 | — | — | WO | disclosed |
| US-20120077941-A1 | POLYMERS FUNCTIONALIZED WITH PROTECTED OXIME COMPOUNDS | BRIDGESTONE CORPORATION (JP) | 2012-03-29 | — | — | US | disclosed |
| US-8088868-B2 | oximation of cojugated homopolymers formed by addtion polymerization of conjugated diene monomer in the presence lanthanide copmpounds as polymerization catalysts; polymers used in the manufacture of tires having reduced hysteresis | BRIDGESTONE CORPORATION (JP) | 2012-01-03 | — | — | US | disclosed |
| US-20080146745-A1 | POLYMERS FUNCTIONALIZED WITH PROTECTED OXIME COMPOUNDS | BRIDGESTONE CORPORATION (JP) | 2008-06-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160297820-A1 | DIMERIZER COMPOUND | BID, BMP4, GCG | METAP2 68/4885METAP1 76/4885GLRA3 2525/4885 |
| US-20200306376-A1 | COMPOSITIONS AND METHODS FOR TARGETED TUMOR IMMUNOTHERAPY | CD47, CD274, CD74 | METAP2 1424/4885METAP1 1048/4885GLRA3 3226/4885 |
| US-12630859-B2 | Method for transcriptome analysis of single cells | RNGTT, METTL16, ELL | METAP2 3322/4885METAP1 2339/4885GLRA3 4680/4885 |
| US-12618832-B2 | Identification of cognate pairs of ligands and receptors | CD14, MSR1, GPR174 | METAP2 1474/4885METAP1 992/4885GLRA3 253/4885 |
| US-20260132451-A1 | RESOLVING SPATIAL ARRAYS BY PROXIMITY-BASED DECONVOLUTION | RNGTT, ADAR, CPSF1 | METAP2 2467/4885METAP1 3192/4885GLRA3 4363/4885 |
| US-20240197884-A1 | COMPOSITIONS AND METHODS FOR TARGETED TUMOR IMMUNOTHERAPY | CD47, CD274, CD2 | METAP2 1702/4885METAP1 1427/4885GLRA3 3291/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.